Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Sheng Guo

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Annals of Surgical Oncology|February 4, 2012
Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritoneiHaroon Asif Choudry, Arun Mavanur, Mark E O'Malley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2011
Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanomaHaiyan Xiao, Yibing Peng, Yuan Hong, et al.
Nature Communications|November 10, 2018
Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2Zuqiang Liu, Yan Ge, Haiyan Wang, et al.
Journal of the National Cancer Institute|April 4, 2002
Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228Xiaodan Yu, Z Sheng Guo, Monica G Marcu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2011
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancerJun Li, Mark O'Malley, Julie Urban, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in miceYasuhiro Terazaki, Shojiro Yano, Kentaro Yuge, et al.
Annals of Surgical Oncology|August 21, 2015
Complement Inhibition: A Novel Form of Immunotherapy for Colon CancerStephanie Downs-Canner, Deepa Magge, Roshni Ravindranathan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2013
Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunizationHaiyan Xiao, Yibing Peng, Yuan Hong, et al.
Cancer Biology & Therapy|November 8, 2007
Redirecting adaptive immunity against foreign antigens to tumors for cancer therapyWenxian Hu, John J Davis, Hongbo Zhu, et al.
Hepatology (Baltimore, Md.)|October 15, 2013
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinomaYuan Hong, Yibing Peng, Z Sheng Guo, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Annals of Surgical Oncology|February 4, 2012
Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritoneiHaroon Asif Choudry, Arun Mavanur, Mark E O'Malley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2011
Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanomaHaiyan Xiao, Yibing Peng, Yuan Hong, et al.
Nature Communications|November 10, 2018
Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2Zuqiang Liu, Yan Ge, Haiyan Wang, et al.
Journal of the National Cancer Institute|April 4, 2002
Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228Xiaodan Yu, Z Sheng Guo, Monica G Marcu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2011
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancerJun Li, Mark O'Malley, Julie Urban, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in miceYasuhiro Terazaki, Shojiro Yano, Kentaro Yuge, et al.
Annals of Surgical Oncology|August 21, 2015
Complement Inhibition: A Novel Form of Immunotherapy for Colon CancerStephanie Downs-Canner, Deepa Magge, Roshni Ravindranathan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2013
Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunizationHaiyan Xiao, Yibing Peng, Yuan Hong, et al.
Cancer Biology & Therapy|November 8, 2007
Redirecting adaptive immunity against foreign antigens to tumors for cancer therapyWenxian Hu, John J Davis, Hongbo Zhu, et al.
Hepatology (Baltimore, Md.)|October 15, 2013
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinomaYuan Hong, Yibing Peng, Z Sheng Guo, et al.
Pageof 3